5-Bromo-2,4-Dimethoxypyrimidine: Handling & Application Protocol

5-Bromo-2,4-dimethoxypyrimidine is a versatile halogenated pyrimidine building block widely employed in medicinal chemistry and materials science for the construction of complex heterocyclic scaffolds via cross-coupling and nucleophilic aromatic substitution reactions.

CAS Number

7752-89-8

Molecular Formula

C₆H₇BrN₂O₂

Molecular Weight

219.04 g/mol

Appearance

White to off-white crystalline solid

Recommended Storage

Store at 2–8 °C in a tightly sealed container, away from light and moisture

Primary Applications

Suzuki–Miyaura coupling, nucleophilic aromatic substitution, heterocyclic scaffold synthesis

SKU

B121815

Safety and Pre-Handling Precautions

Before working with 5-Bromo-2,4-dimethoxypyrimidine (SKU B121815), consult the current Safety Data Sheet (SDS) available from Aladdin Scientific. As a brominated aromatic compound, it should be treated as a potential irritant to skin, eyes, and the respiratory tract.

Recommended personal protective equipment (PPE) includes nitrile gloves, safety goggles, and a laboratory coat. All weighing and transfer operations should be performed in a well-ventilated fume hood. Avoid generating dust during handling of the solid form.

Waste disposal must comply with local regulations for halogenated organic compounds. Do not discharge into drains or waterways.

Solubility and Solution Preparation

5-Bromo-2,4-dimethoxypyrimidine is soluble in common organic solvents including dichloromethane (DCM), tetrahydrofuran (THF), dimethyl sulfoxide (DMSO), ethyl acetate, and acetonitrile. It has limited solubility in water and non-polar solvents such as hexane.

Preparation of a stock solution:

1. Allow the sealed vial to equilibrate to room temperature before opening to avoid moisture condensation on the cold solid.
2. Accurately weigh the required amount of reagent on an analytical balance inside a fume hood.
3. Transfer to an appropriate dry, inert vessel and add the selected anhydrous solvent (e.g., anhydrous DMSO or DCM).
4. Stir or vortex gently until complete dissolution is achieved. If necessary, gentle warming (≤40 °C) may aid dissolution.
5. Filter through a 0.22 µm PTFE syringe filter if a particle-free solution is required.

Prepare solutions fresh or store sealed under inert atmosphere (N₂ or Ar) at 2–8 °C. Long-term storage of stock solutions is not recommended without verification of stability.

Synthetic Applications and Reaction Protocols

5-Bromo-2,4-dimethoxypyrimidine is a highly useful electrophilic building block in heterocyclic chemistry. The C–Br bond at the 5-position provides a handle for transition-metal-catalyzed cross-coupling reactions, while the methoxy groups at the 2- and 4-positions serve as masked amino or hydroxyl functionalities that can be converted under acidic or nucleophilic conditions.

A. Suzuki–Miyaura Cross-Coupling (General Procedure)

1. Combine 5-Bromo-2,4-dimethoxypyrimidine (1.0 equiv), arylboronic acid (1.2 equiv), Pd(PPh₃)₄ or Pd(dppf)Cl₂ (2–5 mol%), and K₂CO₃ or Cs₂CO₃ (2.0 equiv) in a Schlenk flask.
2. Add degassed 1,4-dioxane/water (4:1 v/v) as solvent.
3. Purge with N₂ or Ar for 15 minutes, seal, and heat to 80–100 °C for 12–18 hours under inert atmosphere.
4. Cool to room temperature, dilute with ethyl acetate, wash with brine, dry over MgSO₄, and concentrate under reduced pressure.
5. Purify by column chromatography (silica gel, ethyl acetate/hexane gradient).

B. Nucleophilic Aromatic Substitution (SNAr)

1. Dissolve 5-Bromo-2,4-dimethoxypyrimidine (1.0 equiv) in anhydrous DMSO or NMP.
2. Add the nucleophile (amine, thiol, or alkoxide; 1.1–2.0 equiv) and a base such as K₂CO₃ or DIPEA (2.0 equiv) if required.
3. Stir at 60–120 °C (temperature is nucleophile-dependent) until TLC or LC-MS indicates consumption of starting material.
4. Work up appropriately and purify the product.

Note: Reactivity at the 4-position methoxy group is typically higher due to the greater electron-deficiency at that position.

Analytical Characterization and Quality Checks

Upon receipt of 5-Bromo-2,4-dimethoxypyrimidine (B121815), routine quality verification is recommended before use in sensitive synthetic steps.

• TLC: Visualize under UV light (254 nm). A single spot confirms purity as a preliminary check.
• ¹H NMR (400 MHz, CDCl₃): Expected signals include a singlet for the aromatic H at C-6 (~δ 8.3 ppm) and two singlets for the two distinct –OCH₃ groups (~δ 3.9–4.0 ppm). Exact chemical shifts should be verified against literature or an in-house reference spectrum.
• GC or HPLC Purity: Target purity ≥97% by GC or HPLC area normalization, consistent with the Aladdin Scientific certificate of analysis (CoA).
• Mass Spectrometry: ESI-MS or EI-MS should display the characteristic isotope pattern for a mono-brominated compound, with M and M+2 peaks in approximately 1:1 ratio.

Always cross-reference results with the CoA supplied with the batch. Contact Aladdin Scientific technical support if analytical data deviates significantly from the CoA specification.

Storage, Stability, and Disposal

Storage: Store 5-Bromo-2,4-dimethoxypyrimidine at 2–8 °C in a tightly closed container under dry conditions, protected from light. Exposure to moisture and air should be minimized to prevent potential degradation or hydrolysis of the methoxy groups over extended periods.

Stability: As a crystalline solid stored under recommended conditions, the compound is expected to be stable for at least 24 months from the date of manufacture when the container remains unopened. Once opened, re-seal tightly and consider backfilling the headspace with inert gas (N₂ or Ar) for extended storage. Stability of prepared solutions should be verified by the end user.

Disposal: Dispose of waste material, including contaminated solids, solutions, and PPE, in accordance with all applicable local, regional, and national regulations governing halogenated organic waste. Do not discharge into sanitary sewers or the environment. Consult your institution's environmental health and safety (EHS) office for guidance.

Frequently asked questions

What solvents are recommended for dissolving 5-Bromo-2,4-dimethoxypyrimidine?

5-Bromo-2,4-dimethoxypyrimidine dissolves well in polar organic solvents such as DMSO, DCM, THF, ethyl acetate, and acetonitrile. Water and non-polar solvents like hexane are not recommended due to poor solubility.

Can 5-Bromo-2,4-dimethoxypyrimidine be used in palladium-catalyzed cross-coupling reactions?

Yes, the C–Br bond at the 5-position makes this compound an excellent substrate for Suzuki–Miyaura, Negishi, and other palladium-catalyzed cross-coupling reactions. Standard Pd(0) or Pd(II) precatalysts with appropriate ligands and bases are recommended under inert atmosphere conditions.

How should I handle the methoxy groups if I need to access the corresponding hydroxyl or amino pyrimidine?

The methoxy groups in 2- and 4-positions can be selectively or fully deprotected. Acidic hydrolysis (e.g., HCl in water or acetic acid) can convert methoxy groups to hydroxyl groups, yielding hydroxypyrimidine derivatives. Aminolysis with primary or secondary amines under heating can displace the methoxy groups to provide aminopyrimidine products, often proceeding preferentially at the 4-position.

What is the shelf life of 5-Bromo-2,4-dimethoxypyrimidine and how should it be stored after opening?

When stored at 2–8 °C in a sealed, dry, and light-protected container, the compound is expected to remain stable for at least 24 months unopened. After opening, re-seal the container tightly and consider purging the headspace with N₂ or Ar to extend stability. Always verify material quality by TLC or NMR before use in critical reactions.

Is 5-Bromo-2,4-dimethoxypyrimidine suitable for use as a building block in medicinal chemistry programs?

Yes, pyrimidine-containing scaffolds are prevalent in approved pharmaceuticals and drug candidates. 5-Bromo-2,4-dimethoxypyrimidine provides versatile handles for diversification via cross-coupling at C-5 and substitution at C-2 and C-4, making it a valuable intermediate for medicinal chemistry SAR campaigns.

References

1. Miyaura N, Suzuki A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem Rev. 1995;95(7):2457–2483. doi:10.1021/cr00039a007
2. Clayden J, Greeves N, Warren S. Organic Chemistry. 2nd ed. Oxford University Press; 2012. Chapter on aromatic heterocycles and nucleophilic aromatic substitution.
3. Taylor RD, MacCoss M, Lawson ADG. Rings in drugs. J Med Chem. 2014;57(14):5845–5859. doi:10.1021/jm4017625

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.